Antibiotics should only be used for a maximum of 3 months and they only work for about half of people with acne. When they do work at all, they provide only temporary relief. They do not dramatically clear the skin on their own, and must be combined with other treatments. Perhaps even more concerning is the fact that antibiotics create strains of resistant bacteria that can then be spread from person to person. For all of these reasons, doctors are prescribing antibiotics for acne less than in previous decades.
Antibiotics have been a mainstay of acne treatment for decades, despite the fact that it is well known that they never completely clear acne and must always be administered alongside topical treatments.1-6 They should only be used for a maximum of 3 months and thus, even when they do help reduce acne, offer only temporary relief. Oral antibiotics help kill acne bacteria (P. acnes) in people who are not resistant to their effects and also help reduce inflammation.7-10 Topical antibiotics do not kill acne bacteria, but do help reduce inflammation.11Oral and topical antibiotics should never be used at the same time.
It has long been noted that antibiotics only work for about half of the population, and produce only moderate effectiveness.12 When they do help, they often only work for a short period of time. Acne tends to "get used to" both oral and topical antibiotic treatments and become resistant to it.7,13 It has become accepted practice that antibiotics must always be used in conjunction with other topical treatments because this helps reduce the chance for resistance, and because antibiotics do not work well enough on their own. As more research comes to light, it appears antibiotics are not helping clear acne as well as they once did. Researchers theorize this may be directly related to increased bacterial resistance across the population.13
A large study conducted by the British Journal of Dermatology studied 4274 acne patients and found that since 1991 an average of 51% of patients harbored colonies of resistant bacteria.14 Other studies have shown similar levels of antibiotic resistant acne bacteria.15-20 Interestingly, researchers are finding similar levels of resistance in both patients treated with antibiotics and those untreated as well, although those untreated have somewhat lower levels of resistance.21 This is because it is quite easy to pass antibiotic resistant strains of bacteria to people close to you.22
How Resistance Happens
On a microscopic level, geneticists and biologists are finding multiple possible reasons why this occurs. The first reason is gene mutation within a bacteria cell.8,23-25 Bacteria have also been observed banding together and producing biofilms, a coating which slows penetration of antibacterial medication.10
All antibiotics are well known to create resistant strains of bacteria, and these resistant strains of bacteria now colonize upwards of half of the population.26-27 However, antibiotics have side effects beyond creating resistant bacteria. Oral antibiotics have more side effects than topical antibiotics and commonly cause gastrointestinal disorders (diarrhea, nausea, stomach cramps) and skin reactions. Depending on which antibiotic is prescribed, neurological problems (dizziness, vertigo) and photosensitivity (increased sensitivity to the sun) are also common. Less frequent side effects include permanent bluish-gray discoloration of the skin, permanent yellow/gray/brown discoloration of teeth, and sudden outbreaks of acne. In rare cases, oral antibiotics can cause auto-immune diseases (i.e. lupus), irreversible hearing loss, and heart problems which can lead to death.22,28-31
Topical antibiotics have fewer side effects but can also be absorbed through the skin and into the body and cause gastrointestinal problems. Upon application, topical antibiotics commonly cause peeling, skin irritation, including redness, dryness, and burning.22,28
Neither oral nor topical antibiotics should be used while attempting to become pregnant, while pregnant, or while breast feeding unless specifically directed by a physician.28
What to Do about It
First, if your doctor attempts to prescribe antibiotics for your acne, ask her why she wants you to do this and if there are other options you can try instead. If you are prescribed antibiotics from a doctor, do not stop your course before speaking with her about it since this can make it more likely that you will create resistant strains of bacteria that will be with you for the rest of your life.
Also keep in mind that benzoyl peroxide kills 99.9% of bacteria almost instantly and when used correctly will reliably and completely clear acne. It will never cause antibiotic resistance or the potential for systemic or long-term side effects and can be used for as long as you need to use it until you naturally grow out of acne.
If you have severe, widespread and deeply scarring acne, Accutane (isotretinoin) is also an option, but comes with severe and potentially long-term side effects and must be entered into carefully alongside a trusted physician.
I took oral and/or topical antibiotics for a year or so altogether during high school and college which is far longer than is prudent. Oral antibiotics did nothing for me and my skin did not improve nor get worse while on them. My skin worsened when I was put on clindamycin (clindamycin phosphate 1%), a topical antibiotic, but in retrospect this was likely because I stopped using benzoyl peroxide and instead started using clindamycin and sulfur, the two prescriptions my doctor wanted me to try. Antibiotics for me were like a bad joke—promising help but delivering nothing. It is more than likely that I now harbor colonies of resistant bacteria. Accutane cleared me up temporarily, but my acne returned post-Accutane. The Acne.org Regimen here at Acne.org finally got me cleared up for good."
The Experts at Acne.org
Our team of medical doctors, biology & chemistry PhDs, and acne experts work hand-in-hand with Dan (Acne.org founder) to provide the most complete information on all things acne. If you find any errors in this article, kindly use this Feedback Form and let us know.
- Costa, C. S. & Bagatin, E. Evidence on acne therapy. Sao Paulo Med. J. 18, 193-197 (2013).
- Leyden, J. J. Antibiotic resistance in the topical treatment of acne vulgaris. Cutis. 73(6 Suppl), 6-10 (2004).
- Leyden, J. J., Wortzman, M. & Baldwin, E. K. Antibiotic-resistant Propionibacterium acnes suppressed by a benzoyl peroxide cleanser 6%. Cutis. 82, 417-21 (2008).
- Leyden, J. J. Effect of topical benzoyl peroxide/clindamycin versus topical clindamycin and vehicle in the reduction of Propionibacterium acnes. Cutis. 69, 475-480 (2002).
- Worret, W. I. & Fluhr, J. W. [Acne therapy with topical benzoyl peroxide, antibiotics and azelaic acid]. J. Dtsch. Dermatol. Ges. 4, 293-300 (2006).
- Kircik, L. H. Ther role of benzoyl peroxide in the new treatment paradigm for acne. J. Drugs Dermatol. 12, s73-76 (2013).
- Leyden, J. & Levy, S. The development of antibiotic resistance in Propionibacterium acnes. Cutis. 67(2 Suppl), 21-24 (2001).
- Leyden, J. J. Current issues in antimicrobial therapy for the treatment of acne. J. Eur. Acad. Dermatol. Venereol. 15 Suppl 3, 51-55 (2001).
- Ochsendorf, F. Systematic therapy of acne vulgaris. J. Dtsch. Dermatol. Ges. 4, 828-841 (2006).
- Thevarajah, S., Balkrishnan, R., Camacho, F. T., Feldman, S. R. & Fleischer, A. B. Jr. Trends in prescription of acne medication in the US: shift from antibiotic to non-antibiotic treatment. J. Dermatolog. Treat. 16, 224-228 (2005).
- Dreno, B. Topical antibacterial therapy for acne vulgaris. Drugs. 64, 2389-2397 (2004).
- Ozolins, M. et al. Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne. Health Technol. Assess. 9, iii-212 (2005).
- Eady, A. E., Cove, J. H. & Layton, A. M. Is antibiotic resistance in cutaneous propionibacteria clinically relevant? : implications of resistance for acne patients and prescribers. Am. J. Clin. Dermatol. 4, 813-831 (2003).
- Coates, P. et al. Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study. Brit. J. Dermatol. 146, 840-848 (2002).
- Luk, N. M. et al. Antibiotic-resistant Propionibacterium acnes among acne patients in a regional skin centre in Hong Kong. J. Eur. Acad. Dermatol. Venereol. 27, 31-36 (2013).
- Nakase, K. Nakaminami, H., Noguchi, N., Nishijima, S. & Sasatsu, M. First report of high levels of clindamycin-resistant Propionibacterium acnes carrying erm(X) in Japanese patients with acne vulgaris. J. Dermatol. 39, 794-796 (2012).
- Narahari, S., Gustafson, C. J. & Feldman, S. R. What’s new in antibiotics in the management of acne? G. Ital. Dermatol. Venereol. 147, 227-238 (2012).
- Chon, S. Y. et al. Antibiotic overuse and resistance in dermatology. Dermatol. Ther. 25, 55-69 (2012).
- Toyne, H., Webber, C., Collignon, P., Dwan, K. & Kljakovic, M. Propionibacterium acnes (P. acnes) resistance and antibiotic use in patients attending Australian general practice. Australas. J. Dermatol. 53, 106-111 (2012).
- Dreno, B., Reynaud, A., Moyse, D., Habert, H. & Richet, H. Erythromycin-resistance of cutaneous bacterial flora in acne. Eur. J. Dermatol. 11, 549-553 (2001).
- Del Rosso, J. Q., Leyden, J. J., Thiboutot, D. & Webster, G. F. Antibiotic use in acne vulgaris and rosacea: clinical considerations and resistance issues of significance to dermatologists. Cutis. 82(2 Suppl 2), 5-12 (2008).
- Oudenhoven, M. D., Kinney, M. A., McShane, D. B., Burkhart, C. N. & Morrell, D. S. Adverse Effects of Acne Medications: Recognition and Management. Am. J. Clin. Dermatol. 16, 231-242 (2015).
- Ishida, N. et al. Antimicrobial susceptibilities of Propionibacterium acnes isolated from patients with acne vulgaris. Microbiol. Immunol. 52, 621-624 (2008).
- Ross, J. I. et al. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia. Br. J. Dermatol. 144, 339-346 (2001).
- Coates, P. et al. Efficacy of oral isotretinoin in the control of skin and nasal colonization by antibiotic-resistant propionibacteria in patients with acne. Br. J. Dermatol. 153, 1126-1136 (2005).
- Eady, E. A., Gloor, M. & Leyden, J. J. Propionibacterium acnes resistance: A world wide problem. Dermatology. 206, 11-16 (2003).
- Ross, J. I. et al. Antibiotic-resistant acne: lessons from Europe. Br. J. Dermatol. 148, 467-478 (2003).
- Tripathi, S. V. et al. Side effects of common acne treatments. Expert Opin. Drug Saf. 12, 39-51 (2013).
- McMullan, B. J. & Mostaghim, M. Prescribing azithromycin. Australian Prescriber Web. 38, 87-90 (2015).
- Turowski, C. B. & James, W. D. The Efficacy and Safety of Amoxicillin, Trimethoprim-Sulfamethoxazole, and Spironolactone for Treatment-Resistant Acne Vulgaris. Adv. Dermatol. 23, 155-163 (2007).
- Gillies M, et al. Common harms from amoxicillin: a systematic review and meta-analysis of randomized placebo-controlled trials for any indication. CMAJ. 187, E22-E31 (2015).
- Bojar, R. A. & Holland, K. T. Acne and Propionibacterium acnes. Clin. Dermatol. 22, 375-379 (2004).
- Del Rosso, J. Q. Selection of therapy for acne vulgaris: balancing concerns about antibiotic resistance. Cutis. 82(5 Suppl),12-16 (2008).
- Dr Kno B. General antibiotic therapy in acne. [Article in French] La Revue du praticien. 52, 841-843 (2002).
- Garner, S. E., Eady, E. A., Popescu, C., Newton, J. & Li, W. A. Minocycline for acne vulgaris: efficacy and safety. Cochrane Database Syst. Rev. 1, CD002086 (2003).
- Leyden, J. J., Del Rosso, J. Q. & Webster, G. F. Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: a status report. Dermatol. Clin. 27, 1-15 (2009).
- McInturff, J. E. et al. Granulysin-derived peptides demonstrate antimicrobial and anti-inflammatory effects against Propionibacterium acnes. J. Invest. Dermatol. 125, 256-263 (2005).
- Mills, O. Jr, Thornsberry, C., Cardin, C. W., Smiles, K. A. & Leyden, J. J. Bacterial resistance and therapeutic outcome following three months of topical acne therapy with 2% erythromycin gel versus its vehicle. Acta Derm. Venereol. 82, 260-265 (2002).
- Oprica, C. et al. Antibiotic-resistant Propionibacterium acnes on the skin of patients with moderate to severe acne in Stockholm. Anaerobe. 10, 155-164 (2004).
- Qureshi, A. Survival of antibiotic-resistant Propionibacterium acnes in the environment. 14th European Congress of Clinical Microbiology and Infectious Diseases 2004, Prague, poster presentation. Abstract number: 902_p818. Accessed online on the 8th of April, 2009.
- Zouboulis, C. C. & Piquero-Martin, J. Update and future of systemic acne treatment. Dermatology. 206, 37-53 (2003).